For example, an LTR12C locus acts as promoter for the lncRNA SWI/SNF complex antagonist associated with prostate cancer 1 (SchLAP1), which is overexpressed in about 25% of prostate cancers, where it suppresses the anti-tumor activity of the chromatin-modifying SWI/SNF complex (26, 119, 120). This evidence concerns the gene SCHLAP1 and neoplasm.